Scarica l'app Stockscreener
13.02
3.42%
0.43
Personalis Inc Borsa (PSNL) Ultime notizie
Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com Australia
Personalis CEO Christopher Hall sells $1.31m in company stock By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $675,488 in company stock - Investing.com
Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Personalis (PSNL) CEO sells 100K shares after exercising options - Stock Titan
Form 144 Personalis For: 26 June By Investing.com - Investing.com Canada
PSNL: Form 144 lists 51,251 shares to be sold; prior 10b5-1 sales noted - Stock Titan
Broker files Form 144 as Christopher Hall sells 100,000 PSNL shares (PSNL) - Stock Titan
Personalis, Inc. Actuals & Estimates (NASDAQ:PSNL) - TradingView
PSNL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Personalis, Inc. – NASDAQ:PSNL - TradingView
Personalis stock hits 52-week high at 12.53 USD By Investing.com - Investing.com South Africa
Personalis stock hits 52-week high at 12.53 USD - Investing.com
Personalis Inc (PSNL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
Personalis Inc (PSNL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Numerous Personalis Insiders Sold Stock: Not A Positive Omen - 富途牛牛
Q1 2026 Personalis Inc Earnings Call Transcript - GuruFocus
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Personalis Inc (PSNL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Personalis Inc (PSNL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Personalis Inc (PSNL) Institutional Confidence - TradingKey
Personalis Inc (PSNL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Personalis Inc (PSNL) Valuation: PE, PB & Fair Value Analysis - TradingKey
PSNL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines on Weak ResultsRetail Earnings Report - newsline.com
Personalis (NASDAQ: PSNL) director receives 6,250 RSU award in Form 4/A update - Stock Titan
Lightspeed funds (NASDAQ: PSNL) report 5.8% Personalis stake after in-kind distributions - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: Loss Wider Than Expected, Stock DipsPost-Announcement Reaction - newsline.com
Personalis blood collection kits receive EU regulatory approval - Investing.com UK
Personalis (PSNL) Receives CE Mark Approval for Blood Collection Kits - GuruFocus
Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing - Moomoo
Personalis blood collection kits receive EU regulatory approval By Investing.com - Investing.com Nigeria
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits - Business Wire
Personalis, Inc. Hits Day Low of $10.39 Amid Price Pressure - MarketsMojo
Personalis, Inc. Hits New 52-Week High of $11.84, Up 763.64% - MarketsMojo
Personalis CFO Aaron Tachibana sells $480,400 in company stock By Investing.com - Investing.com India
Personalis CFO Aaron Tachibana sells $480,400 in company stock - Investing.com UK
Personalis (NASDAQ: PSNL) CFO sells 40,000 shares under 10b5-1 plan - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates Amid Revenue Reporting GapsNegative Surprise Momentum - newsline.com
Aaron L. Tachibana (PSNL) exercises 40,000 options; prior 38,799 10b5-1 sale - Stock Titan
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? - The Globe and Mail
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesEPS Estimate Trend - newsline.com
Personalis Data Highlights Early Cancer Recurrence Detection - Clinical Lab Products
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 - BioSpace
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Personalis Insider Sold Shares Worth $449,292, According to a Recent SEC Filing - marketscreener.com
Personalis CFO and COO Aaron Tachibana sells $449,292 in stock By Investing.com - Investing.com South Africa
1.76%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):